---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-112645"
form_type: "8-K"
ticker: "AARD"
cik: "0001774857"
company_name: "Aardvark Therapeutics, Inc."
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:37:01.852197+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aardvark Therapeutics updates corporate presentation; no material specifics disclosed

## Summary
- Company updated corporate presentation dated September 2025 for investor meetings.
- Filing includes only cover and disclaimer; no pipeline, financial, or guidance changes detailed.
- No specific numbers or events from the presentation were included in the filing.

## SEC filing metadata
- accession: 0000950170-25-112645
- form_type: 8-K
- ticker: AARD
- cik: 0001774857
- company_name: Aardvark Therapeutics, Inc.
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1774857/000095017025112645/0000950170-25-112645-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1774857/000095017025112645/ck0001774857-20250902.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-112645
- JSON: https://secwatch.observer/filing/0000950170-25-112645.json
- Plain text: https://secwatch.observer/filing/0000950170-25-112645.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.